Past research projects (2008-2010)
|
Researcher |
Research centre |
Project name |
Focus of research |
|
Benoit Barbeau |
Université du Québec à Montréal (UQAM), Quebec |
Functional comparisons of the antisene proteins encoded by the various HTLV viruses |
|
|
Isabelle Bourdeau |
Hôtel-Dieu de Montréal, Quebec |
Characterization of Wnt/beta-catenin signaling in adrenocortical tumours |
|
|
Pascal Chartrand |
Université de Montréal, Quebec |
E2F-regulated microRNAs and cell cycle progression |
Multiple cancers |
|
University of Ottawa, Ontario |
The Contribution of Specific Protein Arginine Methyltransferases and their substrates to Breast Cancer Tumorigenesis |
||
|
Michael E. Cox |
Jack Bell Research Centre, Vancouver, British Columbia |
Characterizing ERG Transformation of Prostatic Epithelial Cells |
|
|
Gerardo Ferbeyre |
Université de Montréal, Quebec |
CHES1, a forkhead DNA binding protein with tumour suppressor activities |
Multiple cancers |
|
Nicolas Gévry |
Université de Sherbrooke, Quebec |
Role of histone H3K27 demethylase JMJD3 in estrogen-dependant transcription and breast cancer |
|
|
Matthias Götte |
McGill University, Montreal, Quebec |
Interaction between the polymerase of the hepatitis C virus and different classes of inhibitors |
|
|
Douglas Gray |
Ottawa Health Research Institute, Ontario |
Ubiquitin pools as a potential therapeutic target in lung cancer |
|
|
Margaret Hough |
Sunnybrook Research Institute, Toronto, Ontario |
HOX11 Transcriptional Regulation of Target Genes in T-ALL |
|
|
Perry L. Howard |
University of Victoria, British Columbia |
A Small Molecule Approach to Rewiring Erb2 Signalling in Breast Cancer |
|
|
Meredith Irwin |
The Hospital for Sick Children, Toronto, Ontario |
Role of p63 and SATB2 in chemoresistance in HNSCC (head and neck squamous cell carcinoma) |
|
|
Xiaoyan Jiang |
British Columbia Cancer Agency, Vancouver, British Columbia |
Molecular and functional characterization of an AHI-1-BCR-ABL interaction complex in chronic myeloid leukemia |
|
|
Kenneth Kao |
Memorial University of Newfoundland, St. John's, Newfoundland |
Regulation of Ribosome Biogenesis by Pygopus in Epithelial Ovarian Cancer |
|
|
Svetlana Komarova |
McGill University, Montreal, Quebec |
Tumour-induced osteoclast resistance to bisphosphonate action |
|
|
Centre de recherche du CHUL (CHUQ), Quebec, Quebec |
Identification of protein partners required for YB-1 to confer chemoresistance in breast tumors |
Breast cancer, Chemotherapy |
|
|
David LeBrun |
Queen's University, Kingston, Ontario |
Developing a B-cell model for leukemia induction by E2A-PBX1 |
Leukemia, Children and young adult cancers |
|
University of Ottawa, Ontario |
Control of filopodia production by elongation factor eEF1A2 |
||
|
University of Western Ontario, London, Ontario |
Rational design of novel molecular-targeted inhibitors of cancer cell proliferation. |
Multiple cancers, Targeted chemotherapy |
|
|
Université de Montréal, Quebec |
Role of MEK 1/2 signalling in chromosomal instability and colorectal cancer progression |
||
|
Anne-Marie Mes-Masson |
Hopital Notre-Dame du CHUM, Montreal, Quebec |
Involvement of IkappaB kinase-epsilon (IKKe) and IL-6 dysregulation in prostate cancer progression |
|
|
Roger Moorehead |
University of Guelph, Ontario |
Akt isoforms in IGF-IR-induced mammary tumour growth and progression |
|
|
McGill University Health Centre, Montreal, Quebec |
Role of the tumour suppressor PTEN (Phosphatase and Tensin homolog deleted on chromosome Ten) in ErbB-2 induced mammary tumorigenesis |
||
|
Lois Mulligan |
Queen's University, Kingston, Ontario |
RET receptor-Interactions with the Cadherin-Catenin Adhesion Complex |
|
|
Torsten Nielsen |
Vancouver Hospital & Health Sciences Centre, British Columbia |
CSF1 pathway inhibitors in primary xenograft models of soft tissue tumors |
Sarcoma, Targeted chemotherapy |
|
Robin Parks |
Ottawa Health Research Institute, Ontario |
Characterization of oncolytic adenovirus vectors designed to specifically infect cancer cells |
Gene therapy |
|
Université de Sherbrooke, Quebec |
Identifying signal transduction pathways regulated by malignant ascites |
||
|
Lisa Porter |
University of Windsor, Ontario |
Role of Spy1 in Cellular Senescence |
Multiple cancers |
|
Isabelle Royal |
Hôpital Notre-Dame du CHUM, Montreal, Quebec |
Regulation of VEGF-dependent signaling and angiogenic responses by the DEP-1 protein tyrosine phosphatase |
Multiple cancers, Targeted chemotherapy |
|
Martin Simard |
Hôtel-Dieu de Québec, Quebec |
Extensive study of the RNA interference pathway: a new hope to battle against Cancer |
Multiple cancers |
|
Andrew Swan |
University of Windsor, Ontario |
Identification of Cks-SCFSkp2 Substrates in Drosophila |
Multiple cancers |
|
Fumio Takei |
British Columbia Cancer Agency, Vancouver, British Columbia |
Anti-tumour immune responses mediated by NKDC |
Immunotherapy |
|
Montreal General Hospital, Quebec |
Deletion analysis of BRCA1 and BRCA2 loci in high risk breast and/or ovarian cancer families of French Canadian descent |
||
|
Eva Turley |
University of Western Ontario, London, Ontario |
Mechanisms for the oncogenic effects of breast cancer susceptibility oncogene, RHAMM/HMMR. |
|
|
Luc Vallieres |
Centre hospitalier de l'Université Laval (CHUL), Quebec, Quebec |
Interactions between brain tumour cells and the immune system |
Brain & Nervous system tumours, Immunotherapy |
|
Peter Whyte |
McMaster University, Hamilton, Ontario |
Regulation of E2F4 by Phosphorylation |
Multiple cancers |
|
Nadine Wiper-Bergeron |
University of Ottawa, Ontario |
The Inhibition of MyoD Expression and skeletal Muscle Differentiation by C/EBPbeta in Cancer Cachexia |
Multiple cancers |
